Invision Medi Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-09-2024
- Paid Up Capital ₹ 0.10 Cr
as on 29-09-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.94 Cr
as on 29-09-2024
- Revenue -20.51%
(FY 2023)
- Profit -29.03%
(FY 2023)
- Ebitda 29.11%
(FY 2023)
- Net Worth 8.44%
(FY 2023)
- Total Assets -9.31%
(FY 2023)
About Invision Medi Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 Cr.
The company currently has active open charges totaling ₹2.94 Cr.
Mukeshkumar, Nataraj Nanjundappa, and Chirag Mukeshkumar serve as directors at the Company.
- CIN/LLPIN
U24234KA2011PTC057213
- Company No.
057213
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Invision Medi Sciences Private Limited offer?
Invision Medi Sciences Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Cardiovascular Drugs & Medication, Cardiac Drugs, Common Disease Medicines, Antihistamines, Hair Growth Medicine, Anti Infective Drugs & Medicines, Malaria Medicine, Pharmaceutical Capsules.
Who are the key members and board of directors at Invision Medi Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukeshkumar  | Managing Director | 22-Feb-2011 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nataraj Nanjundappa | Director | 12-Oct-2013 | Current |
| Chirag Mukeshkumar | Director | 04-Apr-2016 | Current |
Financial Performance and Corporate Structure Insights of Invision Medi Sciences.
Invision Medi Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.51% decrease. The company also saw a substantial fall in profitability, with a 29.03% decrease in profit. The company's net worth moved up by a moderate rise of 8.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invision Medi Sciences?
Unlock access to Invision Medi Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Minova Life Sciences Private Limited
Active 17 years 5 monthsMukeshkumar and Chirag Mukeshkumar are mutual person
Invision Pharma Limited
Active 6 years 5 monthsMukeshkumar, Nataraj Nanjundappa and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Feb 2013 | ₹2.94 Cr | Open |
How Many Employees Work at Invision Medi Sciences?
Invision Medi Sciences has a workforce of 16 employees as of Sep 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invision Medi Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invision Medi Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
